Regulation of pharmaceuticals is a complex task. Andreas Seiter's note reviews the role of drug regulatory authorities in developing countries and discusses how to set priorities in line with the overall health policy agenda.. Most diseases in developing countries could be treated with existing and well-known medicines. However, essential pharmaceuticals often are not available, not accessible, or not used appropriately. As bad or worse, use of substandard...
Exibir mais
DETALHES
-
2005/04/01
-
Informativo
-
32194
-
1
-
1
-
2005/05/04
-
Disclosed
-
Pharmaceuticals: drug regulation in low and middle income countries
-
economic regulatory framework
DOWNLOADS
COMPLETAR RELATÓRIO
Versão oficial do documento (pode conter assinaturas, etc.)
-
Total Downloads** : 1225
*A versão do texto é um OCR incorreto e está incluído unicamente em benefício de usuários com conectividade lenta.